Company news
Tenaya Therapeutics, Inc. news in 2023
Tenaya Therapeutics, Inc.'s news releases, calls and decks from 2023, newest first.
Tenaya Therapeutics to Participate at the 35th Annual Piper Sandler Healthcare Conference
November 20, 2023
Tenaya Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
November 7, 2023
Tenaya Therapeutics Announces FDA Clearance to Begin Clinical Testing of TN-401 Gene Therapy for the Treatment of PKP2-Associated Arrhythmogenic Right Ventricular Cardiomyopathy
October 25, 2023
Tenaya Therapeutics Presents Encouraging New Clinical and Preclinical Data from HDAC6 Inhibitor Program TN-301 for the Potential Treatment of Heart Failure with Preserved Ejection Fraction at the 2023 HFSA Annual Scientific Meeting
October 8, 2023
Tenaya Therapeutics Doses First Patient in the MyPeak-1™ Phase 1b Clinical Trial of TN-201 for the Treatment of MYBPC3-Associated Hypertrophic Cardiomyopathy
October 4, 2023
Tenaya Therapeutics Publishes Preclinical Data in Circulation Highlighting the Clinical Potential of Cellular Reprogramming for Cardiac Regeneration
October 1, 2023
Tenaya Therapeutics to Present Data for TN-301 and TN-201 at Upcoming Medical Conferences
September 20, 2023
Tenaya Therapeutics to Participate at the 21st Annual Morgan Stanley Global Healthcare Conference
August 30, 2023
Tenaya Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update
August 8, 2023
Tenaya Therapeutics to Participate at the 43rd Annual Canaccord Genuity Growth Conference
August 1, 2023
Tenaya Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update
May 9, 2023
Tenaya Highlights Growing Capabilities in AAV Manufacturing, Capsid Engineering and Expansion into Gene Editing with Six Abstracts Accepted for Presentation at the ASGCT 26th Annual Meeting
May 2, 2023
Tenaya Therapeutics Receives FDA Fast Track Designation for TN-201
May 1, 2023
Tenaya Therapeutics to Participate at Chardan's 7th Annual Genetic Medicines and Cell Therapy Manufacturing Summit
April 20, 2023
Tenaya Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
March 7, 2023
Tenaya Therapeutics to Participate in Upcoming Investor Conferences
February 6, 2023
Tenaya Therapeutics Announces TN-201 IND Clearance and Anticipated 2023 Milestones
January 8, 2023